FELERAZ

Serial Number 85398995
606

Registration Progress

Application Filed
Aug 16, 2011
Under Examination
Sep 25, 2012
Approved for Publication
Jul 31, 2012
Published for Opposition
Jul 31, 2012
Registered

Trademark Image

FELERAZ

Basic Information

Serial Number
85398995
Filing Date
August 16, 2011
Published for Opposition
July 31, 2012
Abandonment Date
April 28, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 28, 2014
Classes
042

Rights Holder

Aegerion Pharmaceuticals, Inc.

03
Address
101 Main Street, STE 1850
Cambridge, MA 02142

Ownership History

Aegerion Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Aegerion Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Paul T. Clark

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

26 events
Date Code Type Description Documents
Apr 28, 2014 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 28, 2014 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Oct 1, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 28, 2013 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 25, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 25, 2013 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 11, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 10, 2013 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 10, 2013 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 21, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 21, 2013 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 25, 2012 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 31, 2012 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 31, 2012 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 11, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 28, 2012 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 27, 2012 ALIE A ASSIGNED TO LIE Loading...
Jun 8, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 7, 2012 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 7, 2012 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 7, 2012 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 8, 2011 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 8, 2011 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 8, 2011 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 7, 2011 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 19, 2011 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 042
PHARMACEUTICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF CARDIOVASCULAR DISEASE, IN PARTICULAR, HYPERLIPIDEMIA
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042